Robert Malmstrom

Robert Malmstrom is a computational chemist currently serving as a Senior Advisor in Structure Based Drug Design at Eli Lilly and Company. Having earned a Ph.D. in Biochemistry from The University of Texas Medical Branch at Galveston, they have extensive experience in computer-aided drug design, specializing in ligand and structure-based methods. They previously held positions such as Senior Scientist at Vividion Therapeutics and Consultant in Computer-Aided Drug Discovery at the Center for Translational Drug Discovery at UC-San Diego. Robert has also contributed to research leadership as the Executive Director of the National Biomedical Computation Resource.